Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Leandro Cerchietti
DLBCL
Daniel Thomas
Myelofibrosis
Carma Bylund
Equity in Access
Mendel Goldfinger
MDS/AML trials for the elderly
Alfred Garfall
myeloma immunotherapy
Catherine Smith
leukemia
Yan Liu
MDS
Pooja Khandelwal
bone marrow transplantation
Steven Park
follicular lymphoma
Manyi Wei
acute megakaryoblastic leukemia
Michael Keller
COVID-19, immunotherapy
Anouchka Laurent
T-cell lymphoma
Taishi Yonezawa
AML
Sergei Doulatov
Leukemias
Yubin Zhou
peripheral T cell lymphoma
Mark Murakami
follicular lymphoma
Noemí Puig Morón
Myeloma
Bailee Kain
AML and African ancestry
Lawrence Boise
CART and myeloma
Lindsey Montefiori
pediatric leukemia
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Maximilian Stahl
AML immunotherapy
Venkata Lokesh Battula
immunotherapy and AML
Adam de Smith
pediatric ALL and Down Syndrome
Grzegorz Nowakowski
Clinical trial access
Eugenio Morelli
Myeloma
James Rubenstein
Lymphoma of the Central Nervous System
Fahmin Basher
transplant and GvHD
Sahand Hormoz
MPN
Jianhua Yu
myeloma immunotherapy
Catherine Diefenbach
DLBCL immunology
Paul Beavis
immunotherapy in myeloma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Adi Nagler
Bronchiolitis obliterans after transplant
Srividya Swaminathan
pediatric, immunotherapy
Constellation Pharmaceuticals
myeloproliferative neoplasms
Gianpietro Dotti
CAR T and AML
Yiman Liu
Epigenetics and leukemia
Catriona Jamieson
cancer stem cell biology
Hao Jiang
DNA biology and leukemia
Jianguo Tao
Mantle Cell Lymphoma
Kymera Therapeutics
protein degraders, TCL, LGLL, AML
Paolo Strati
Non-Hodgkin Lymphoma
Eric Padron
CMML
Gaurav Goyal
Erdheim-Chester Disease
Daniel Herranz
T-ALL
Michael Kharas
leukemia
Craig Jordan
AML
Christopher Porter
Leukemia, lymphoma
Alieen Rowan
Adult T cell leukemia/lymphoma
Siddhartha Jaiswal
preleukemia
Ravi Bhatia
transplantation
Marina Konopleva
MDS/AML metabolism
Ryan Wilcox
T-cell lymphoma
Rgenta Therapeutics
RNA-targeting, blood cancer
Jonathan Licht
DNA biology, myeloma
Daniel Pollyea
AML
Carl June
CAR T immunotherapy
Suzanne Lentzsch
Myeloma
Kura Oncology
MLL leukemia, AML
Saar Gill
AML immunotherapy
Christian Marinaccio
MLL leukemias
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Daniel Lucas
bone marrow and leukemia biology
Steven Horwitz
T-cell lymphomas
Nizar Bahlis
Myeloma immunotherapy
Bing Carter
p53 mutant AML
Jayna Mistry
aging and leukemias
Alexey Danilov
lymphoma
Thomas LeBlanc
palliative care
Julia Maxson
AML
Nicoletta Cieri
AML and transplantation
Caroline Arber
myeloma CAR-T
Keisuke Ito
blood cancer stem cells and MDS metabolism
Jake Shortt
precision therapy for aggressive lymphomas
Timothy Graubert
AML and MDS biology
Mark Dawson
B-ALL and CAR-T resistance
Coleman Lindsley
AML/MDS
Markus Muschen
leukemia and lymphoma biology
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Sheng Li
Aging and AML
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Jonathon Cohen
lymphoma clinical trial access in Georgia
Philippe Armand
follicular lymphoma
Affimed
immunotherapy, HL, PTCL
Ruben Carrasco
Myeloma
Nataly Cruz-Rodriguez
T-ALL and metabolism
Madhav Dhodapkar
multiple myeloma immunotherapy
Jolanta Grembecka
leukemia therapeutics
Sarah Tasian
pediatric leukemias
Jaroslaw Maciejewski
bone marrow failure
Jing Yang
Myeloma
Kasey Leger
pediatric blood cancers
Enterome
vaccine, FL, MZL
Piers Patten
COVID-19
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Caner Saygin
T-ALL
Sham Mailankody
Myeloma immunotherapy clinical trials
Caron Jacobson
lymphoma and immunotherapy
Meng Li
Equity in Access
Anushree Vichare
Equity in Access
Teresa Palomero
Peripheral T-cell Lymphoma
Kirk Schultz
pediatric transplantation
BioInvent International
immunotherapy, indolent NHL, CTCL
Eric Pietras
AML
Wendy Stock
T-cell ALL
Anthony Letai
improving CAR-T
Inhye Ahn
CLL
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Courtney Jones
AML metabolism
Takeshi Sugio
T-cell lymphoma
Faron Pharmaceuticals
immunotherapy, MDS
Soheil Meshinchi
pediatric AML
Steven Treon
Lymphomas and Waldenstrom's
Matthew Frank
Lymphoma CART therapy
Courtney DiNardo
clinical trials, AML
Gareth Morgan
smoldering myeloma, MGUS
Frederike Kramer
MPNs
Liling Wan
AML
Suman Paul
T cell cancers and immunotherapy
John DiPersio
trispecific antibody for AML and MDS
H. Irene Su
Equity in Access
Jessica Stewart
Epstein-barr virus and lymphomas
Tycel Phillips
Mantle Cell Lymphoma
Nicolas Nassar
pediatric leukemia
Oreofe Odejide
Equity in Access
Christopher Flowers
clinical trial access
Dan Landau
cancer evolution biology
Nicola Vannini
Aging and CAR-T success
Huda Salman
CMML
F. Lennie Wong
Equity in Access
Trent Hall
MDS
Catherine Bollard
pediatric blood cancers and immunotherapy
Andrew Lane
BPDCN
Nirav Shah
CAR-T for lymphoma
Mala Shanmugam
myeloma
Armin Rashidi
gut bacteria and transplant success
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Kathleen Sakamoto
pediatric AML
Sam Butterworth
CMML
George Daley
"off-the-shelf" CAR-T and CAR-NK
Jalpa Doshi
Equity in Access
Luca Busino
DLBCL
Pietro Genovese
transplant and AML
Riccardo Dalla-Favera
lymphoma (DLBCL)
ImCheck Therapeutics
immunotherapy, AML
Alison Moskowitz
lymphoma therapeutics
Christopher Booth
BPDCN
Britta Will
Leukemia and pre-leukemia
Rong Lu
preleukemia, leukemia
Sriram Sundaravel
AML stem cells
John Leonard
lymphoma research
Michael Green
lymphoma biology
Areej El-Jawahri
transplant survivorship
Logan Spector
childhood leukemia epidimiology
Qing Yi
Novel CAR-T
Jeffrey Magee
pediatric AML
Jonas Jutzi
myeloproliferative neoplasms
Peter Croucher
Multiple Myeloma
Susan Schwab
cancer immunology
Megan McNerney
AML/MDS
Amin Sobh
Myeloma biology
Jaehyuk Choi
T-cell lymphoma
Rizwan Romee
Immunotherapy
Jenny Wang
AML
Stacie Dusetzina
Equity in Access
Michaela Reagan
Multiple Myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Christine Zhang
AML
Robert Soiffer
transplantation
Daisuke Nakada
preleukemia, leukemia
Solu Therapeutics
immunotherapy, CMML
Martin Dreyling
Mantle Cell Lymphoma
Wendy Béguelin
follicular lymphoma
Ann-Kathrin Eisfeld
Racial diversity in AML
Marco Ruella
Immunotherapy for T-cell lymphoma
Daniel Starczynowski
MDS and AML
Bruno Paiva
smoldering myeloma
Yoke Seng Lee
AML
Jennifer Lewis
URM Student
Jennifer Trowbridge
aging and leukemia
Xu Ji
Equity in Access
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Arash Alizadeh
blood cancer biology and diagnosis
Matteo Bellone
Smoldering multiple myeloma
Tak Mak
Immunotherapy
Helen Parsons
Equity in Access
John Crispino
MPNs, myelofibrosis
Sisi Chen
leukemia
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Nitin Jain
CLL
Shannon Maude
Immunotherapy for ALL
Robert Orlowski
(Smoldering) Multiple Myeloma
Ravindra Majeti
preleukemia, AML
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Stephen Nimer
myeloid cancer biology
Ricky Johnstone
lymphoma and myeloma
Cailin Collins
Leukemia and pre-leukemia
Jennifer Woyach
CLL trials
Christian Steidl
B-cell lymphomas
Margaret Shipp
lymphoma biology
Yibin Yang
Lymphoma
Simona Colla
Myeloma biology
George Vassiliou
Leukemia Prevention
Jing Fu
myeloma
Jeetayu Biswas
splicing in myeloid diseases
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Neha Mehta-Shah
T-cell lymphoma
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Reina Takeda
AML
Jeremy Baeten
AML
Adam Olszewski
Follicular and marginal zone lymphoma
Koichi Takahashi
AML/MDS
Shazia Nakhoda
Equity in Access
Ari Melnick
epigenetics and lymphoma
Thomas Kipps
Hairy Cell Leukemia
Stephen Oh
myeloproliferative neoplasms
Raymond Mailhot
Equity in Access
Liran Shlush
pre-leukemia
Kimberly Stegmaier
childhood blood cancers
Ana Vujovic
AML
Peter Klein
MDS
Fenghuang Zhan
Myeloma and bone disease
Marc Seifert
Hairy cell leukemia
Michael Wang
Mantle Cell Lymphoma
Michael Savona
MDS and leukemia
Justine Kahn
pediatric leukemia and lymphoma
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Elliot Stieglitz
CMML
Thomas Koehnke
leukemia
Tanya Siddiqi
clinical trial access
Qingyu Luo
BPDCN
Brian Walker
smoldering myeloma, MGUS
Omar Abdel-Wahab
Hairy cell leukemia
Lev Kats
myeloma and epigenetics
Brian Dalton
DNA mutations and myeloid cancers
Sigurður Kristinsson
Smoldering myeloma
Alec Zhang
myeloma, immunotherapy
Paolo Caimi
CAR-T clinical trial for CLL
Rajni Kumari
AML
Frederick Locke
lymphoma and immunotherapy
Jun Qi
Myeloma
Stephen Gottschalk
pediatric leukemia and CAR-T
Bingyi Chen
AML immunotherapy
Dane Vassiliadis
blood cancer biology
Kerry Rogers
CLL
Eirini Papapetrou
blood cancer stem cells
Siegfried Janz
Myeloma immunotherapy
Alex Kentsis
pediatric leukemias
Tyler Parsons
MPN and AML
Lucy Godley
preleukemia
Randall Davis
CLL
Ronald Levy
immunotherapies, COVID-19
Joachim Yahalom
Lymphoma
Carl Allen
pediatric blood cancers
William Matsui
Myeloma
Julia Paczkowska
immunobiology of Hodgkin's disease
Lakshmi Nayak
brain tumors in lymphoma
Dimericon Therapeutics
dimericons, blood cancer
Richard Lock
T-ALL
Lori Muffly
Equity in Access
Roberta Zappasodi
lymphoma, immunotherapy
Hong Wen
AML
Tomasz Skorski
myeloproliferative neoplasms, AML
Enrico Tiacci
Hairy cell leukemia
Mark Hamilton
DLBCL and CAR-T
Jean Koff
Disparities in DLBCL
Roland Walter
Antibody-based AML therapies
Amit Verma
AML/MDS
Grant Challen
preleukemia, leukemia